CTN-0067: Comparing Treatments for HIV-Positive Opioid Users in an Integrated Care Effectiveness Study (CHOICES): Scale-Up

November 8, 2021 /

Principal Investigator
Todd Korthuis, MD, MPH
Oregon Health & Science University
korthuis@ohsu.edu

This study aims to build on lessons learned from the CHOICES pilot study (CTN-0055) and to advance understanding of XR-NTX adoption in HIV primary care settings. This open-label randomized clinical trial compares effect of office-based XR-NTX vs. TAU on HIV viral suppression at 24 weeks from randomization for HIV-infected participants with untreated opioid use disorder and HIVRNA PCR > 200 copies/ml at baseline.

    Node Involvement

    Lead Node(s):

  • Western States Node

    • All Participating Nodes:

  • Florida Node Alliance
  • Western States Node